Amanote Research
Register
Sign In
P2.16-45 Should Patients With Stage IB Non-Small Cell Lung Cancer Receive Adjuvant Chemotherapy?
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.1520
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
J. Wang
W. Nan
C. Lv
S. Yan
Y. Yang
Publisher
Elsevier BV
Related search
P2.16-36 Adjuvant Chemotherapy Is Effective for Completely Resected Stage IB Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Safety of Adjuvant Chemotherapy With Carboplatin and Weekly Paclitaxel for Pathological Stage IB-IIIB Non-Small Cell Lung Cancer
Japanese Journal of Lung Cancer
Oncology
Respiratory Medicine
Pulmonary
Which Patients With Stage III Non-Small Cell Lung Cancer Should Undergo Surgical Resection?
Oncologist
Cancer Research
Medicine
Oncology
Benefit of Adjuvant Chemotherapy After Resection of Stage II (T1-2n1m0) Non-Small Cell Lung Cancer in Elderly Patients
Annals of Surgical Oncology
Oncology
Surgery
Oncologic Treatment of Non-Small Cell Lung Cancer Part B: Adjuvant Chemotherapy for Resected Non-Small Cell Lung Carcinoma
Survival After Surgery in Stage IA and IB Non–Small Cell Lung Cancer
American Journal of Respiratory and Critical Care Medicine
Pulmonary
Critical Care
Respiratory Medicine
Intensive Care Medicine
P2.01-113 Prognostic Roles of Neoadjuvant and Adjuvant Chemotherapy for Treating Patients With Operable Stage III-N2 Non-Small Cell Lung Cancer (NSCLC)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Nursing Care for Patients With Non-Small Cell Lung Cancer Receiving Adjuvant Chemotherapy: Evidence–based Implications for Practice
Canadian Oncology Nursing Journal
Chemotherapy for Non-Small Cell Lung Cancer in Elderly Patients
Chest
Cardiology
Critical Care
Cardiovascular Medicine
Intensive Care Medicine
Pulmonary
Respiratory Medicine
